COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03581942
Brief Title: Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)

First Submitted : June 26, 2018
First Submitted that Met QC Criteria : June 27, 2018
First Posted : July 10, 2018

Last Update Submitted that Met QC Criteria : June 10, 2020
Last Update Posted : June 12, 2020